Phathom Pharmaceuticals, Inc. (PHAT) — SC 13D/A Filings

SC 13D/A Filings (5)

• Frazier Life Sciences Amends Phathom Pharma Stake — Aug 22, 2024 Risk: medium
  Frazier Life Sciences Public Fund, L.P. has amended its Schedule 13D filing regarding Phathom Pharmaceuticals, Inc. as of August 22, 2024. The filing indicates
• Frazier Life Sciences Amends Phathom Pharma Stake — Jun 6, 2024 Risk: medium
  Frazier Life Sciences Public Fund, L.P. and related entities have filed an amendment to their Schedule 13D, indicating a change in their beneficial ownership of
• Takeda Amends Phathom Ownership Filing — Apr 10, 2024 Risk: low
  Takeda Pharmaceutical Company Limited, through its filing on April 10, 2024, has amended its Schedule 13D/A regarding Phathom Pharmaceuticals, Inc. This amendme
• Takeda Pharma Amends Phathom Pharma Stake Disclosure — Apr 1, 2024 Risk: low
  Takeda Pharmaceutical Company Limited, through its filing on April 1, 2024, has amended its Schedule 13D/A regarding Phathom Pharmaceuticals, Inc. This amendmen
• Takeda Amends Phathom Stake, Signals Ownership Change — Jan 25, 2024
  Takeda Pharmaceutical Company Limited filed an Amendment No. 5 to its Schedule 13D, indicating a change in its beneficial ownership of Phathom Pharmaceuticals,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX